KR950702838A - 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4) - Google Patents

인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4) Download PDF

Info

Publication number
KR950702838A
KR950702838A KR1019950700598A KR19950700598A KR950702838A KR 950702838 A KR950702838 A KR 950702838A KR 1019950700598 A KR1019950700598 A KR 1019950700598A KR 19950700598 A KR19950700598 A KR 19950700598A KR 950702838 A KR950702838 A KR 950702838A
Authority
KR
South Korea
Prior art keywords
interleukin
hiv infection
hiv replication
pharmaceutical composition
inhibiting hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019950700598A
Other languages
English (en)
Korean (ko)
Inventor
슈왈츠 제롬
Original Assignee
에릭 에스. 딕커
쉐링 코포레이션(Schering Corporation)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에릭 에스. 딕커, 쉐링 코포레이션(Schering Corporation) filed Critical 에릭 에스. 딕커
Publication of KR950702838A publication Critical patent/KR950702838A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1019950700598A 1992-08-19 1993-08-17 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4) Ceased KR950702838A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93213492A 1992-08-19 1992-08-19
US07/932134 1992-08-19
PCT/US1993/007587 WO1994004179A1 (en) 1992-08-19 1993-08-17 Method for inhibiting hiv replication using il-4

Publications (1)

Publication Number Publication Date
KR950702838A true KR950702838A (ko) 1995-08-23

Family

ID=25461831

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950700598A Ceased KR950702838A (ko) 1992-08-19 1993-08-17 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)

Country Status (22)

Country Link
US (1) US5700461A (enExample)
EP (1) EP0656785B1 (enExample)
JP (1) JP2711182B2 (enExample)
KR (1) KR950702838A (enExample)
CN (1) CN1086437A (enExample)
AT (1) ATE163860T1 (enExample)
AU (1) AU683427B2 (enExample)
CA (1) CA2142862C (enExample)
CZ (1) CZ38095A3 (enExample)
DE (1) DE69317428T2 (enExample)
ES (1) ES2113549T3 (enExample)
FI (1) FI950696A7 (enExample)
HU (1) HUT72709A (enExample)
IL (1) IL106717A0 (enExample)
MX (1) MX9305016A (enExample)
NO (1) NO950599L (enExample)
NZ (1) NZ255735A (enExample)
PL (1) PL307508A1 (enExample)
SK (1) SK21295A3 (enExample)
TW (1) TW291439B (enExample)
WO (1) WO1994004179A1 (enExample)
ZA (1) ZA936018B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2214551T3 (es) * 1995-11-02 2004-09-16 Schering Corporation Terapia de infusion continua de citocinas a baja dosis.
US20050124645A1 (en) * 1998-04-20 2005-06-09 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US20030232738A1 (en) * 1998-04-20 2003-12-18 National Jewish Medical And Research Center Method and composition for increasing CD4+ T lymphocyte immune responsiveness
US20040132161A1 (en) * 1998-04-20 2004-07-08 Finkel Terri H. Methods and compositions for increasing CD4lymphocyte immune responsiveness
US6194391B1 (en) * 1998-06-24 2001-02-27 Emory University 3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol
US6734192B1 (en) 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
JPH02485A (ja) * 1987-08-03 1990-01-05 Yuu Honshiyo 新規なヒトインターロイキン４、該因子を発現させるための組換えベクター及びそのベクターにより形質転換された形質転換体
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus
WO1991014450A1 (en) * 1990-03-21 1991-10-03 Schering Corporation Use of il-4 to enhance immune response to infectious antigenic challenges
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
EP0490006B1 (en) * 1990-12-13 1994-06-22 Schering-Plough Pharmaceutical compositions for the treatment of B-cell malignancies

Also Published As

Publication number Publication date
FI950696A0 (fi) 1995-02-16
NO950599D0 (no) 1995-02-17
CA2142862C (en) 2000-05-30
TW291439B (enExample) 1996-11-21
CA2142862A1 (en) 1994-03-03
JP2711182B2 (ja) 1998-02-10
HU9500487D0 (en) 1995-04-28
AU683427B2 (en) 1997-11-13
FI950696L (fi) 1995-02-16
EP0656785B1 (en) 1998-03-11
ES2113549T3 (es) 1998-05-01
CN1086437A (zh) 1994-05-11
JPH07506116A (ja) 1995-07-06
EP0656785A1 (en) 1995-06-14
NZ255735A (en) 1997-06-24
WO1994004179A1 (en) 1994-03-03
ATE163860T1 (de) 1998-03-15
DE69317428T2 (de) 1998-07-02
AU5007593A (en) 1994-03-15
ZA936018B (en) 1994-06-13
PL307508A1 (en) 1995-05-29
HUT72709A (en) 1996-05-28
NO950599L (no) 1995-02-17
IL106717A0 (en) 1993-12-08
SK21295A3 (en) 1997-01-08
MX9305016A (es) 1994-02-28
FI950696A7 (fi) 1995-02-16
US5700461A (en) 1997-12-23
CZ38095A3 (en) 1995-12-13
DE69317428D1 (de) 1998-04-16

Similar Documents

Publication Publication Date Title
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
NO931267L (no) Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
RU95113492A (ru) Терапевтическая комбинация, содержащая человеческий интерферон, его применение, фармацевтический препарат, упаковка и способ лечения
GEP20002297B (en) Alpha-Substituted Pyrimidine-Thioalhyl and Alkyl-Ether Compounds, Method for Treatment of Individual Infected with the Immunodeficiency Virus
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
DK0876152T3 (da) Hidtil ukendt administrering af thrombopoietin
ATE84217T1 (de) Fragmente und fraktionen von heparin mit wirkung gegen hiv.
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
ATE192926T1 (de) Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren
Schulof et al. Treatment of HTLV-III/LAV-infected patients with D-penicillamine
RU94038588A (ru) Способ лечения вторичного иммунодефицита (вид)
KR960701657A (ko) 피부 상처 치료용 인자 XIII (Factor XIII for treatment of skin wounds)
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
ES2160927T3 (es) Composiciones farmaceuticas que comprenden interferon alfa humano natural.
ATE83381T1 (de) Verwendung von rekombiniertem menschlichem alpha- interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
NO950599L (no) Fremgangsmåte for inhibering av HIV-replikasjon ved anvendelse av IL-4
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
ATE222107T1 (de) Verwendung einer kombination von beta-sitosterol und beta-sitosterol-glukosid zur herstellung eines medikamentes zur behandlung von hiv- infektion
DK1143976T3 (da) Beta-D-2', 3'-didehydro-2', 3'-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
NO931338L (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus
NO931337L (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 19950216

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980223

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19980518

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19980223

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I